ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels

키워드

참고문헌 (43)

1. American Diabetes Association, "9. Cardiovascular disease and risk management", Diabetes Care, 40(Suppl 1), pp.S75~S87 (2017)[DOI]
2. Stone NJ, "2013 ACC", AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63(25)[DOI]
3. Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members, "An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia: full report", J Clin Lipidol, 8, pp.29~60 (2014)[DOI]
4. Kyoung Hwa Ha, "Current status of managing diabetes mellitus in Korea", The Korean Journal of Internal Medicine, 31(5), pp.845~850 (2016), 대한내과학회[DOI]
5. Ai M, "Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study", Clin Chem, 56, pp.967~976 (2010)[DOI]
6. Tae Seok Lim, "Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study", The Korean Journal of Internal Medicine, 31(6), pp.1110~1119 (2016), 대한내과학회[DOI]
7. Ivanova EA, "Small dense low-density lipoprotein as biomarker for atherosclerotic diseases", Oxid Med Cell Longev, 2017, pp.1273042~ (2017)
8. Cromwell WC, "Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg", dl, 2006, pp.98, 1599~1602
9. Walldius G, "The apoB", apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy: a review of the evidence, 2006, pp.259, 493~519
10. Kaneva AM, "The apolipoprotein B", apolipoprotein A-I ratio as a potential marker of plasma atherogenicity, 2015, pp.2015, 591454~
11. Millan J, "Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention", Vasc Health Risk Manag, 5, pp.757~765 (2009)
12. Yusuf S, "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study", Lancet, 364, pp.937~952 (2004)[DOI]
13. Meisinger C, "Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA", KORA Augsburg cohort study, 2005, pp.26, 271~278
14. Walldius G, "High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study", Lancet, 358, pp.2026~2033 (2001)[DOI]
15. Walldius G, "The apoB", apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk, 2004, pp.42, 1355~1363
16. Verges B, "Pathophysiology of diabetic dyslipidaemia: where are we?", Diabetologia, 58, pp.886~899 (2015)[DOI]
17. Kannan S, "LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database", Indian J Endocrinol Metab, 18, pp.502~504 (2014)[DOI]
18. Bonora E, "Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies", J Clin Endocrinol Metab, 68, pp.374~378 (1989)[DOI]
19. Young RP, "The short insulin tolerance test: feasibility study using venous sampling", Diabet Med, 13, pp.429~433 (1996)[DOI]
20. Alberti KG, "The short insulin tolerance test is safe and reproducible", Diabet Med, 16, pp.352~353 (1999)[DOI]
21. Park SW, "Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes", Atherosclerosis, 205, pp.309~313 (2009)[DOI]
22. Chambless LE, "Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study", Am J Epidemiol, 151, pp.478~487 (2000)[DOI]
23. 홍서나, "Carotid artery intima-media thickness in Behcet's disease patients without significant cardiovascular involvement", The Korean Journal of Internal Medicine, 23(2), pp.87~93 (2008), 대한내과학회
24. Baldassarre D, "Measurement of carotid artery intima-media thickness in dyslipidemic patients increases the power of traditional risk factors to predict cardiovascular events", Atherosclerosis, 191, pp.403~408 (2007)[DOI]
25. Naqvi TZ, "Carotid intima-media thickness and plaque in cardiovascular risk assessment", JACC Cardiovasc Imaging, 7, pp.1025~1038 (2014)[DOI]
26. Touboul PJ, "Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011", Cerebrovasc Dis, 34, pp.290~296 (2012)[DOI]
27. Kim SK, "Ratio of waist-to-calf circumference and carotid atherosclerosis in Korean patients with type 2 diabetes", Diabetes Care, 34, pp.2067~2071 (2011)[DOI]
28. Packard CJ, "Lipoprotein heterogeneity and apolipoprotein B metabolism", Arterioscler Thromb Vasc Biol, 17, pp.3542~3556 (1997)[DOI]
29. Walldius G, "Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy", J Intern Med, 255, pp.188~205 (2004)[DOI]
30. McQueen MJ, "Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study", Lancet, 372, pp.224~233 (2008)[DOI]
31. Canoui-Poitrine F, "Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study", Cerebrovasc Dis, 30, pp.252~259 (2010)[DOI]
32. Thompson A, "Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B", AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies, 2006, pp.259, 481~492
33. Jadhav UM, "Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease", J Assoc Physicians India, 52, pp.370~375 (2004)
34. 정창희, "Association of Apolipoprotein B", Apolipoprotein A1 Ratio and Coronary Artery Stenosis and Plaques Detected by Multi-Detector Computed Tomography in Healthy Population, 2013, pp.28(5), 709~716[DOI]
35. Wallenfeldt K, "Apolipoprotein B", apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men, 2004, pp.35, 2248~2252
36. Goldberg IJ, "Clinical review 124: diabetic dyslipidemia: causes and consequences", J Clin Endocrinol Metab, 86, pp.965~971 (2001)[DOI]
37. Haffner SM, "Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state", Circulation, 101, pp.975~980 (2000)[DOI]
38. Sniderman AD, "Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome", Curr Opin Lipidol, 18, pp.633~637 (2007)[DOI]
39. Bruno G, "Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study", Diabetologia, 49, pp.937~944 (2006)[DOI]
40. Dahlen EM, "Carotid intima-media thickness and apolipoprotein B", apolipoprotein A-I ratio in middle-aged patients with type 2 diabetes, 2009, pp.26, 384~390
41. Anagnostis P, "Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions", Maturitas, 81, pp.62~68 (2015)[DOI]
42. Goff DC Jr, "2013 ACC", AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology, Circulation, pp.2014, 129(25 Suppl 2)[DOI]
43. NACB LMPG Committee Members, "National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease", Clin Chem, 55, pp.378~384 (2009)

관련 논문AI추천